Description
LHC-165 is a benzonaphthyridine TLR7 agonist.
| Product Unit Size | Cost | Quantity | Stock |
|---|
LHC-165 is a benzonaphthyridine TLR7 agonist.
| Cas No. | 1258595-14-0 |
|---|---|
| Purity | ≥99% |
| Formula | C29H32F2N3O7P |
| Formula Wt. | 603.56 |
| IUPAC Name | 3-[5-amino-2-[2-[4-[2-(3,3-difluoro-3-phosphonopropoxy)ethoxy]-2-methylphenyl]ethyl]benzo[f][1,7]naphthyridin-8-yl]propanoic acid |
| Synonym | LHC165 |
| Appearance | Pale yellow powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Zawit M, Swami U, Awada H, et al. Current status of intralesional agents in treatment of malignant melanoma. Ann Transl Med. 2021 Jun;9(12):1038. PMID: 34277838
Inhibitor of T-lymphokine-activated killer cell...
Anthracycline, DNA intercalator; topoisomerase ...
ALK and IGF-1R inhibitor.
Dihydropyridine; L-type Ca2+ channel blocker.
Synephrine is an endogenous alkaloid.
Derivative of methyl caffeate, hydroxycinnamic ...
D-Seco Paclitaxel is an impurity in the product...
Synthetic peptide, retroviral envelope protein ...
Non-nucleoside RT inhibitor.
Synthetic peptice; μOR agonist.
Mycotoxin that has structural similarity to est...
p110β PI3K inhibitor.
NSAID; COX-2 inhibitor.
Phthalide; PPARγ agonist, IMPDH inhibitor, mic...
Mycotoxin that has structural similarity to est...
Non-alkaloid lignan found in Podophyllum,deriva...
Triazole; 14-α demethylase and aromatase inhib...
Camptothecin derivative; topoisomerase I inhibi...
Synthetic non-steroid endocrine disrupter; ER a...
mGluR5 positive modulator.